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OBJECTIVE—Diet composition alters the metabolic states of
adipocytes and hepatocytes in diabetes. The effects of dipeptidyl
peptidase-4 (DPP-4) inhibition on adipose tissue inﬂammation
and fatty liver have been obscure. We investigated the extra-
pancreatic effects of DPP-4 inhibition on visceral fat and the liver.
RESEARCH DESIGN AND METHODS—We investigated diet-
induced metabolic changes in b-cell–speciﬁc glucokinase haplo-
insufﬁcient (Gck
+/2) diabetic mice. We challenged animals with
a diet containing a combination of sucrose and oleic acid (SO) or
sucrose and linoleic acid (SL). Next, we assessed the effects of
a DPP-4 inhibitor, des-ﬂuoro-sitagliptin, on adipose tissue inﬂam-
mation and hepatic steatosis.
RESULTS—The epididymal fat weight and serum leptin level
were signiﬁcantly higher in Gck
+/2 mice fed SL than in mice fed
SO, although no signiﬁcant differences in body weight or adipo-
cyte size were noted. Compared with SO, SL increased the num-
bers of CD11c
+ M1 macrophages and CD8
+ T-cells in visceral
adipose tissue and the expression of E-selectin, P-selectin, and
plasminogen activator inhibitor-1 (PAI-1). DPP-4 inhibition signif-
icantly prevented adipose tissue inﬁltration by CD8
+ T-cells and
M1 macrophages and decreased the expression of PAI-1. The
production of cytokines by activated T-cells was not affected
by DPP-4 inhibition. Furthermore, DPP-4 inhibition prevented
fatty liver in both wild-type and Gck
+/2 mice. DPP-4 inhibition
also decreased the expressions of sterol regulatory element–binding
protein-1c, stearoyl-CoA desaturase-1, and fatty acid synthase, and
increased the expression of peroxisome proliferator–activated
receptor-a in the liver.
CONCLUSIONS—Our ﬁndings indicated that DPP-4 inhibition
has extrapancreatic protective effects against diet-induced adipose
tissue inﬂammation and hepatic steatosis. Diabetes 60:1246–
1257, 2011
T
he prevalence of diabetes and metabolic syn-
drome has increased dramatically in Western
societies and Asia, mainly because of the popu-
larization of high-fat and high-sucrose diets. The
combination of high levels of dietary sugars and fatty acids
causes metabolic abnormalities in multiple organs (1,2). A
hallmark of metabolic syndrome is the expansion of the
visceral adipose tissue, which is under a state of chronic
inﬂammation (3). The accumulation of adipose tissue
macrophages (ATMs) is thought to be a major component
of the chronic inﬂammatory response (4). Nonalcoholic
fatty liver disease (NAFLD) occurs in patients with com-
ponents of metabolic syndrome. The secretome of chron-
ically inﬂamed adipose tissue leads to an altered metabolic
state with insulin resistance and NAFLD (5).
Sucrose is a major carbohydrate constituent of the diet,
and diets rich in sucrose result in hepatic steatosis. Pal-
mitic acid, linoleic acid, and oleic acid are the major fatty
acid components of dietary fat and plasma triglycerides
(6). Although palmitic acid–induced metabolic abnormalities
are well-known, the effects of oleic acid and linoleic acid,
two major unsaturated fatty acids, have not been fully elu-
cidated. Hence, we examined two diet protocols to compare
dietary oleic acid with linoleic acid (7). Both of these diet
protocols contain a similar amount of palmitic acid.
Dipeptidyl peptidase-4 (DPP-4) is responsible for the
degradation of numerous peptides and chemokines that
contain an alanine or proline at position 2. A DPP-4 in-
hibitor, des-ﬂuoro-sitagliptin (DFS), acts by inhibiting the
breakdown of regulatory peptides including incretins such
as glucagon-like peptide-1 (GLP-1) or glucose-dependent
insulinotropic polypeptide (GIP) and increasing insulin
release (8). However, the clinical beneﬁts of DPP-4 in-
hibitor therapy cannot be fully explained by the increase in
insulin release alone, and other mechanisms are thought to
affect b-cell mass, b-cell apoptosis, and other tissues (9–11).
Recently, the extrapancreatic actions of GLP-1 on cardiac
muscle and endothelial cells have frequently been reported
(12). In addition, a GLP-1 receptor agonist exendin-4 im-
proved hepatic steatosis in ob/ob mice (13) and the exoge-
nous expression of GLP-1 reduced hepatic gluconeogenesis
in ob/ob mice (14). Exendin-4 also directly affected human
hepatocytes via the GLP-1 receptor (15). Furthermore,
exendin-4 inhibited monocyte adhesion to endothelial cells
(16) and GLP-1 receptor signaling affected lymphocyte
proliferation (17). However, the beneﬁcial effect of DPP-4
inhibition on diet-induced extrapancreatic effects, especially
on adipose tissue inﬂammation, remains poorly understood.
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ORIGINAL ARTICLEIn this study, we used b-cell–speciﬁc glucokinase haplo-
insufﬁcient (Gck
+/2) mice, which were generated by dis-
rupting the b-cell– and brain-speciﬁc exon (18), to evaluate
the impact of diet on visceral fat and the liver in the
presence of a diabetic state. Gck
+/2 mice are an animal
model of nonobese type 2 diabetes caused by impaired
insulin secretion in response to glucose (18,19). Thus,
Gck
+/2 mice manifest hyperglycemia after glucose loading
as a result of their impaired insulin secretion, but the gene
levels in the liver and adipose tissue are essentially normal.
We assumed that, in combination with environmental
factors such as an SL diet, high glucose or low insulin
levels would induce alterations in the expressions of sev-
eral genes in the liver as well as the adipose tissue in Gck
+/2
mice. We then investigated whether a DPP-4 inhibitor can
prevent nutrient-induced visceral adipose tissue inﬂamma-
tion and NAFLD.
RESEARCH DESIGN AND METHODS
We backcrossed Gck
+/2 mice (18) with C57Bl/6 J mice more than 10 times.
Both the wild-type and Gck
+/2 mice were fed standard chow (MF; Oriental
Yeast, Japan) until 8 weeks of age and then were given free access to the
experimental diets. All the experiments were conducted on male littermates.
All the animal procedures were performed in accordance with the institutional
animal care guidelines and the guidelines of the Animal Care Committee of the
Yokohama City University. The animal housing rooms were maintained at a
constant room temperature (25°C) and on a 12-h light (7:00 A.M.)/dark (7:00 P.M.)
cycle.
Diets. The experimental diets were freshly prepared weekly. The compositions
of the diet containing a combination of sucrose and oleic acid (SO) and the
isocaloric diet containing a combination of sucrose and linoleic acid (SL) are
shown in Supplementary Table 1. Both diets contained a similar amount of
palmitic acid. Wild-type and Gck
+/2 mice were randomly assigned to one of the
two diet groups. The DFS used in this study was prepared by Process Re-
search, Merck Research Laboratories (Rahway, NJ) (8). DFS was adminis-
trated orally by premixing with the SL diet to a concentration of 1.1% because
this concentration of DFS has been found to result in a 90% inhibition of the
plasma DPP-4 activity (20).
Measurement of biochemical parameters and cytokines. Plasma glucose
levels,bloodinsulinlevels,andtriglyceridecontentintheliverweredetermined
with a Glutest Neo Super (Sanwa Chemical), insulin kit (Morinaga), and
Determiner-L TG II kit (Wako Pure Chemical Industries), respectively. Plasma
alanineaminotransferase,freefattyacid,totalcholesterol,LDLcholesterol,and
triglyceride were assayed by enzymatic methods (Wako Pure Chemical In-
dustries).
Histological analysis. Formalin-ﬁxed, parafﬁn-embedded adipose tissue
sections were immunostained with antibodies to F4/80 (Serotec), CD11c (BD
Bioscience), and plasminogen activator inhibitor (PAI)-1 (Santa Cruz). Bio-
tinylated secondary antibodies, a VECTASTAIN elite ABC kit, and a diamino-
benzidine substrate kit (VECTOR) were used to examine the sections using
bright-ﬁeld microscopy, and Alexa Fluor 488-, 555-, and 647-conjugated sec-
ondary antibodies (Invitrogen) were used for ﬂuorescence microscopy. All the
images were acquired using a BZ-9000 microscope (Keyence) or a Carl Zeiss
LSM 510 confocal laser scanning microscope. More than ﬁve tissue sections
from each animal including representative sections of each tissue region were
analyzed.
Liver sections were prepared and stained using a Masson-Goldner staining
kit (Merck) according to the manufacturer’s instructions.
Preparation and ﬂow cytometric analysis of stromal vascular fraction.
The adipose stromal vascular fraction (SVF) was prepared by collagenase
digestion(NittaGelatin) ofepididymalfat tissuefrom each mouse as previously
described (21). For ﬂow cytometry, the SVF pellet was resuspended in
erythrocyte lysis buffer and incubated in staining medium (PBS with 2%
endotoxin-free FBS; 0.1% sodium azide). The cells were incubated with anti-
bodies to CD16/32 (BD Biosciences) to block the Fcg receptors prior to
staining with conjugated antibodies. SVF cells were analyzed for ATMs by
staining with antibodies to F4/80 (serotec) and CD11c (BD Bioscience). SVF
cells were analyzed for T-cell subsets by staining with antibodies to CD3e,
CD4, and CD8 (BD Bioscience), and T-cells were identiﬁed by the expression
of CD3 and gated for analysis. Flow cytometry was performed using a FACS
Canto II (BD Biosciences).
Real-time PCR. Tissue specimens were preserved in RNAlater reagent
(QIAGEN) until the isolation of the total RNA. Total RNA was isolated from
the liver tissue using a QIA shredder and an RNeasy kit (QIAGEN). Total
RNA was isolated from the epididymal fat using an RNeasy lipid tissue kit
(QIAGEN). cDNA was prepared using the Taqman reverse transcriptase kit
(Applied Biosystems) and was subjected to quantitative PCR by performing
Taqman Gene Expression Assays using the Universal Master Mix (7500 real-
time [RT]-PCR system; Applied Biosystems). All probes used in the Taqman
Gene Expression Assays were purchased from Applied Biosystems. Each
quantitative reaction was performed in duplicate. The data were normalized to
the value for b-actin.
Stimulation of T-cells, ELISA, and analysis of intracellular cytokines.
CD4
+ T-cells and CD8
+ T-cells were separated from splenocyte of wild-type or
Gck
+/2 mice by negative and positive selection using auto magnetic cell
sorting as previously described (22). The purity of each cell was .90% as
analyzed by ﬂow cytometry. Cells (2 3 10
5 cells/well) were stimulated with
plate-coated anti-CD3 and anti-CD28 monoclonal antibodies in a total volume
of 0.5 mL in 96-well round bottom plates. T-cells were expanded and main-
tained in the same culture conditions for 3 days.
For antigen-presenting cell (APC) preparation, CD11c
+ splenocytes from
wild-type C57BL/6 mice were cultured at 1 3 10
5 cells/well in a 96-well round-
bottom plate with 1 mg/mL soluble ovalbumin. Splenocytes from homozygous
OT-I TCR-Tg and OT-II TCR-Tg C57BL/6 mice (The Jackson Laboratory) were
prepared and stimulated with APCs at 1 3 10
5 cells/well in a 96-well round-
bottom plate for 3 days.
Exendin-4 was added to culture medium at a concentration of 100 nmol/L.
DFS was added to culture medium at a concentration of 1 mmol/L or 100 mmol/L.
Recombinant soluble human CD26 (rsCD26) (23) was added to culture medium
at a concentration of 0.5 mg/mL.
Concentrations of g-interferon (IFN-g), tumor necrosis factor (TNF)-a,
monocyte chemoattractant protein (MCP)-1, and interleukin (IL)-10 in culture
supernatants were determined using an ELISA kit (R&D systems) according
to the manufacturer’s instructions. Intracellular IFN-g, TNF-a, and MCP-1
synthesis was analyzed by ﬂow cytometry by using a BD Cytoﬁx/Cytoperm
Fixation/Permealization kit with BD GolgiPlug (BD Biosciences) according to
the manufacturer’s instructions.
Statistical analyses. All the data were reported as means 6 SE and analyzed
using Student t test or ANOVAs. Differences were considered signiﬁcant if the
P value was ,0.05.
RESULTS
SL induced adipose tissue hypertrophy but did not
affect body weight in Gck
+/2 mice. Wild-type mice and
Gck
+/2 mice fed an SO diet or an isocaloric SL diet for
25 weeks were evaluated for blood glucose level, body
weight, liver weight, and epididymal fat weight (Fig. 1A).
No signiﬁcant differences in body weight, liver weight,
blood glucose level, or serum insulin concentration were
observed between the SO group and the SL group of either
genotype (Table 1). However, the ratio of the epididymal
fat weight to the body weight of SL-fed Gck
+/2 mice was
signiﬁcantly higher than that of SO-fed Gck
+/2 mice despite
a similar body weight. In wild-type mice, no differences in
the epididymal fat weight were observed between the SO
group and the SL group. The body weight gain and the
food intake of both the wild-type and the Gck
+/2 mice fed
either the SO diet or the SL diet were similar to those of
animals fed a standard chow diet; however, the fasting
blood glucose levels were signiﬁcantly higher among ani-
mals fed a standard chow diet in both the wild-type and the
Gck
+/2 mice (Supplementary Table 2). Among the Gck
+/2
mice, the SL diet decreased insulin secretion at 15 min
after oral glucose loading compared with the SO diet but
did not affect insulin sensitivity after an insulin injection
(Fig. 1B–D). No signiﬁcant differences in the serum lipid
parameters were observed among the four groups
(Supplementary Fig. 1). These results indicated that the SL
diet induced visceral adipose tissue hypertrophy under
diabetic conditions.
SL recruited M1 macrophages to visceral fat and
increased the expression of PAI-1 in Gck
+/2 mice.
Both the wild-type and the Gck
+/2 mice fed either the
SO or the SL diet displayed a similar adipocyte size and
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adipocyte area in all four groups was larger than in the
standard diet–fed mice but smaller than that in the high-fat
diet (HFD32)-fed mice (Supplementary Fig. 2). Consistent
with visceral fat hypertrophy in the Gck
+/2 mice fed the SL
diet, the serum leptin concentration was also signiﬁcantly
increased (Fig. 2B).
An immunohistochemical analysis showed a signiﬁcant
increase in F4/80
+ crown-like structures (CLSs) in Gck
+/2
mice fed the SL diet compared with Gck
+/2 mice fed the SO
diet (Fig. 2D and E). F4/80
+ CLSs were hardly detected in
the epididymal adipose tissue of the wild-type and the
Gck
+/2 mice fed a standard diet (Supplementary Fig. 3). A
phenotypic switch of ATMs from an anti-inﬂammatory M2
polarization state to a proinﬂammatory M1 polarization
state is thought to be responsible for the inﬂammatory
changes in the adipose tissue (21,24). The total numbers of
nucleated cells and CD11c
+ CLSs were also higher among
the Gck
+/2 mice fed the SL diet than among the Gck
+/2
mice fed the SO diet (Fig. 2F). In the wild-type mice, no
signiﬁcant differences in the number of F4/80
+ CLSs and
CD11C
+ CLSs observed in the epididymal fat were seen
between the SO group and the SL group. Because the
production of PAI-1 by ATMs was reported to be a re-
sponse to a nutritional signal (free fatty acid [FFA]) (25),
we examined the PAI-1 expression level in epididymal
fat. The expression of PAI-1 was enhanced surrounding
CD11C
+ CLSs in the Gck
+/2 mice fed the SL diet (Fig. 2G).
The mRNA expression levels of F4/80, CD11c, and PAI-1
were signiﬁcantly higher among the Gck
+/2 mice fed the SL
diet than among the Gck
+/2 mice fed the SO diet (Fig. 2H).
SL induced adipose tissue inﬂammation, inﬁltration
of CD8
+ T-cells, and expression of E-selectin and
P-selectin in Gck
+/2 mice. Next, we isolated the SVF of
cells from the epididymal fat pads of wild-type and Gck
+/2
mice fed either the SO or the SL diet and analyzed them
using ﬂow cytometry. The proportion of F4/80
+ ATMs was
signiﬁcantly higher in the SVF cells of the Gck
+/2 mice
fed the SL diet than in those of the mice fed the SO diet
(Fig. 3A). The proportion of F4/80
+ CD11c
+ cells among
the F4/80
+ ATMs was also higher in the SL group (Fig. 3B
and C). CD4
+ and CD8
+ T-cells have recently been repor-
ted to play crucial roles in the initiation and propagation of
adipose inﬂammation by promoting the recruitment and
activation of macrophages in adipose tissue (26–28). The
proportion of the CD4
+ subset and the CD8
+ subset among
the SVF CD3
+ T-cells was investigated using ﬂow cytom-
etry. The proportion of the CD8
+ T-cell subset was signiﬁ-
cantly higher among the Gck
+/2 mice fed the SL diet
(Fig. 3D and E). No signiﬁcant differences in the SVF cells
FIG. 1. SL-induced impaired insulin secretion in Gck
+/2 mice. A: Experimental protocol. Both the wild-type (WT)a n dGck
+/2 mice were fed
standard chow diet until 8 weeks of age and then given free access to the experimental diets. Experiments were performed on wild-type and Gck
+/2
mice after 25 weeks on the SO (□)o rS L( ■) diet. B: Insulin tolerance (n =1 0 –12). C and D: Glucose tolerance (n =1 0 –12). C: Plasma glucose
levels. ○, wild-type mice on SO diet; ●, wild-type mice on SL diet; △, Gck
+/2 mice on SO diet; ▲, Gck
+/2 mice on SL diet. D: Serum insulin levels.
*P < 0.05.
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in the subsets of splenic T-cells were observed in any of the
groups (Supplementary Fig. 4). Because the expressions of
E-selectin and P-selectin were reportedly enhanced in the
SVF of inﬂamed adipose tissue from obese animals (29),
we measured the level of TNF-a, MCP-1, E-selectin, and
P-selectin expression in the epididymal fat tissue using
RT-PCR. The mRNA expression levels of TNF-a and
MCP-1 tended to be higher in the Gck
+/2 mice fed the SL
diet than in the Gck
+/2 mice fed the SO diet (Fig. 3F). The
expressions of E-selectin and P-selectin in the epididymal
fat of the wild-type and Gck
+/2 mice fed the SL diet were
signiﬁcantly higher than those of the wild-type and Gck
+/2
mice fed the SO diet. However, no signiﬁcant differences
in the serum concentrations of TNF-a or MCP-1 were ob-
served between the mouse groups fed the SL diet and those
fed the SO diet (Fig. 3G and H).
DFS ameliorated SL-induced adipose tissue hypertro-
phy in Gck
+/2 mice. To evaluate DFS as a treatment for
diet-induced adipose tissue inﬂammation, we performed
a 20-week study comparing wild-type or Gck
+/2 mice fed
a diet consisting of SL or SL plus 1.1% DFS (Fig. 4A). The
epididymal fat weight and the body weight of the SL-fed
Gck
+/2 mice tended to be decreased by the addition of DFS
to the diet (Table 2). These body weight changes were
observed only after week 17. No signiﬁcant differences in
the liver weight or the fasting serum insulin concentration
were observed between the SL group and SL plus DFS
group of either genotype. We noted that in Gck
+/2 mice,
DFS improved the glucose tolerance and increased the
serum insulin level after glucose loading but did not affect
insulin sensitivity after an insulin injection (Fig. 4B-D). No
signiﬁcant differences in the serum lipid parameters were
observed among the four groups after chronic DPP-4 in-
hibition (Supplementary Fig. 5). These results indicated
that DFS prevented SL-induced visceral adipose tissue
hypertrophy under diabetic conditions.
DFS prevented the SL-induced recruitment of M1
macrophages to visceral fat by reducing the expres-
sion of PAI-1 in Gck
+/2 mice. Next, we analyzed the
epididymal fat pads of wild-type and Gck
+/2 mice fed the
SL or the SL plus DFS diet for 20 weeks. The adipocyte
area tended to be slightly decreased in the DFS groups,
but the serum adiponectin levels were unaffected (Fig. 5A
and C and Supplementary Fig. 6). In accordance with the
reduced epididymal fat weight, the serum leptin level of
the SL-fed Gck
+/2 mice tended to be decreased by DFS
(Fig. 5B). DFS reduced the number of F4/80
+ CLSs (Fig. 5D
and E), the total nucleated cells, and CD11c
+ CLSs in the
adipose tissue of SL fed-Gck
+/2 mice (Fig. 5F). In wild-type
mice, no signiﬁcant differences in F4/80
+ CLSs and
CD11C
+ CLSs of the epididymal fat were observed by the
administration of DFS. The expression of PAI-1 around
CD11c
+ CLSs was also suppressed by DFS (Fig. 5G). The
mRNA expression analysis also showed that DFS reduced
the expressions of F4/80, CD11c, and PAI-1 in Gck
+/2 mice
(Fig. 5H). Thus, adipose tissue inﬁltration by M1 macro-
phages was prevented by DPP-4 inhibition in a diabetic state.
We also conducted experiments using an SO plus DFS
diet. DFS did not affect the epididymal fat weight or the
number of F4/80
+ CLSs in wild-type and Gck
+/2 mice fed
the SO diet (data not shown).
DFS protected against SL-induced adipose tissue in-
ﬁltration by CD8
+ T-cells but had no impact on the
production of inﬂammatory cytokines by T-cells. Flow
cytometric analyses revealed that DFS signiﬁcantly pre-
vented the SL-induced increases in the ratios of F4/80
+
ATMs (Fig. 6A) and F4/80
+ CD11c
+ cells (Fig. 6B and C)
among the F4/80
+ ATMs in the SL-fed Gck
+/2 mice. The
ratio of CD8
+ subset cells among the CD3
+ SVF T-cells in
the SL-fed Gck
+/2 mice was signiﬁcantly reduced to a level
similar to that seen in the SO-diet group (Fig. 6D and E).
The mRNA expression levels of TNF-a and MCP-1 were
reduced by DFS in Gck
+/2 mice fed the SL diet, but the
difference was not signiﬁcant in TNF-a (Fig. 6F). The
levels of E-selectin and P-selectin expression were not
affected by DFS in any of the mouse groups (Fig. 6F).
No signiﬁcant differences in the serum concentrations of
TNF-a and MCP-1 were observed between the mouse
group fed the SL diet and the group fed the SL-plus-DFS
diet (Fig. 6G and H).
We also investigated the role of DPP-4 inhibition on
T-cell–mediated adipose tissue inﬂammation in vivo. Mu-
rine CD26/DPP-4 (mCD26) was expressed on the surface
of both CD4
+ and CD8
+ T-cells, and the expression of
mCD26 was upregulated 24 h after transient stimulation
(Supplementary Fig. 8). Neither DFS nor exendin-4 af-
fected the production of IFN-g, TNF-a, MCP-1, or IL-10 by
CD4
+ or CD8
+ T-cells from wild-type and Gck
+/2 mice af-
ter stimulation with anti-CD3 and anti-CD28 antibodies
(Supplementary Fig. 9). Intracellular cytokine staining also
showed no signiﬁcant differences in IFN-g,T N F - a,o rM C P - 1
synthesis (Supplementary Fig. 10). In human peripheral
blood cells, exogenous recombinant soluble CD26 (rsCD26)
was able to upregulate the CD86 expression on mono-
cytes and enhance the antigen-speciﬁc T-cell activation via
TABLE 1
Effects of experimental diets at week 25 on body weight, liver weight, epididymal fat weight, blood glucose level, and serum insulin
concentration after a 16-h fast in wild-type and Gck
+/2 mice
Wild-type Gck
+/2
SO SL SO SL
Body weight (g) 41.00 6 2.39 39.67 6 2.39 40.67 6 2.38 41.60 6 1.61
Liver weight (g) 1.87 6 0.20 1.67 6 0.15 2.43 6 0.34 1.87 6 0.15
Epididymal fat weight (g) 0.98 6 0.15 0.89 6 0.26 1.18 6 0.19 1.74 6 0.21
Liver weight/body weight (%) 4.55 6 0.40 4.21 6 0.28 5.87 6 0.51* 4.48 6 0.25
Epididymal fat weight/body weight (%) 2.36 6 0.29 2.15 6 0.58 2.86 6 0.35 4.24 6 0.60†
Glucose (mg/dL) 114 6 3‡ 110 6 4‡ 178 6 9 181 6 6
Insulin (ng/mL) 0.68 6 0.038 0.65 6 0.048 0.69 6 0.036 0.76 6 0.059
Data are means 6 SE. n =8 –10. *P , 0.05 relative to wild-type SL and Gck
+/2 SL. †P , 0.05 relative to wild-type SO, wild-type SL, and Gck
+/2
SO. ‡P , 0.05 relative to Gck
+/2 SO and Gck
+/2 SL.
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duction of IFN-g, TNF-a, MCP-1, or IL-10 by the CD4
+ T-
cells of OT-II mice or the CD8
+ T-cells of OT-I mice were
observed after stimulation with a speciﬁc antigen (ovalbumin
peptide) presented by CD11c
+ splenic APCs in the presence
of DFS, exendin-4, or rsCD26 (Supplementary Fig. 11).
DFS protected against diet-induced hepatic steatosis.
Diets containing a large amount of sucrose reportedly
resulted in fatty liver in mice (32,33). In the current study,
we fed a sucrose-rich diet (36% sucrose diet) to wild-type
and Gck
+/2 mice and investigated the severity of steatosis
in the four groups. Mild steatosis occurred in the livers
of all the groups, but evidence of inﬂammatory cell in-
ﬁltration of the liver was not seen in any of the groups
(Supplementary Fig. 12A). By contrast, steatosis was not
observed in wild-type or Gck
+/2 mice of the same age fed
a standard diet (Supplementary Fig. 13A). When he-
patic steatosis was graded from 1 to 3, as shown in
Supplementary Fig. 14 (34), no signiﬁcant differences in
the grade of steatosis were found among the four groups
FIG. 2. SL-induced inﬁltration of adipose tissue by M1 macrophages and expression of PAI-1. A: Histogram of adipocyte size of the epididymal fat
(n =5 ) .B and C: Serum leptin and adiponectin levels (n =6 –8). D and E: Epididymal fat tissue was stained with anti-F4/80 antibody. The number
of CLSs was counted as described in RESEARCH DESIGN AND METHODS (n =5 ) .F: Epididymal fat tissue was stained with anti-CD11c antibody and DAPI.
G: Epididymal fat tissue was stained with anti–PAI-1 antibody and anti-CD11c antibody. H: Assessment of the level of expression of the mRNAs
indicated in epididymal fat as determined by real-time quantitative RT-PCR and normalization to the b-actin mRNA level (n = 5). Experiments
were performed on wild-type (WT)a n dGck
+/2 mice after 25 weeks on the SO or SL diet. *P < 0.05. (A high-quality digital representation of this
ﬁgure is available in the online issue.)
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liver and the mRNA expression levels of sterol regulatory
element–binding protein (SREBP)-1c, stearoyl-CoA desat-
urase (SCD)-1, peroxisome proliferator–activated receptor
(PPAR)a, SREBP-2, fatty acid synthase (FAS), and TNF-a
were similar in all four groups (Supplementary Fig. 12C
and D). The hepatic expressions of phosphoenolpyruvate
carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase)
were signiﬁcantly increased in mice fed a diet of SO or SL,
compared with mice fed a standard diet (Supplementary
FIG. 3. SL-induced adipose tissue inﬂammation by inﬁltration of CD11c
+ M1 macrophages and CD8
+ T-cells. A: Number of F4/80
+ cells as a pro-
portion of the cells in the SVF of epididymal fat from the mice as determined by ﬂow cytometry (n =5 ) .B: Number of CD11c
+ cells as a proportion
of the F4/80
+ cells in the SVF of epididymal fat from the groups of mice indicated as determined by ﬂow cytometry (n =5 ) .C: Flow cytometric
analysis of CD11c
+ cells among F4/80
+ SVF cells from the epididymal fat of Gck
+/2 mice. D and E: Flow cytometric analysis of the CD4
+ subset and
CD8
+ subset of CD3
+ T-cells in the epididymal fat of the groups of mice indicated (n = 5). F: Assessment of the level of expression of the mRNAs
indicated in epididymal fat as determined by real-time quantitative RT-PCR and normalization to the b-actin mRNA level (n =5 ) .G and H: Serum
TNF-a and MCP-1 levels (n =6 –8). Experiments were performed on wild-type (WT)a n dGck
+/2 mice after 25 weeks on the SO or SL diet. *P < 0.05.
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palatinose, a slowly digestible sucrose analog, instead of
sucrose and an oleic acid diet (PO) for 25 weeks. Steatosis
was not observed in the wild-type or the Gck
+/2 mice fed
the PO diet (Supplementary Fig. 13B).
Next, we investigated the effects of DFS on diet-induced
fatty liver in wild-type and Gck
+/2 mice fed the SL diet.
DFS did not signiﬁcantly affect the liver weight (Table 2).
DFS monotherapy improved steatosis histochemically and
signiﬁcantly decreased the grade of steatosis in both
euglycemic wild-type and hyperglycemic Gck
+/2 mice (Fig.
7A and B). The hepatic triglyceride content was also re-
duced by treatment with DFS (Fig. 7C), and the mRNA
expression levels of SREBP-1c, SCD-1, and FAS were de-
creased and the expression of PPARa was increased by
DFS monotherapy in both genotypes (Fig. 7D). Further-
more, the administration of DFS reduced the hepatic
expression of PEPCK or G6Pase (Fig. 7E). DFS also
ameliorated fatty liver in wild-type and Gck
+/2 mice fed the
SO diet (Supplementary Fig. 13C).
DISCUSSION
Adipose tissue has been shown to be a central driver of
type 2 diabetes progression, establishing and maintaining
a chronic state of low-level inﬂammation (35). Chronic
exposure to high concentrations of glucose and free fatty
acids in the blood affects pancreatic b-cell function, lipid
synthesis in the liver, and lipid storage in adipose tissue.
We here established a nonobese model of diet-induced
adipose tissue inﬂammation and NAFLD in Gck
+/2 mice by
feeding them an SL diet. In wild-type mice, no differences
in epididymal fat weight were observed between the SO
and the SL groups. The body weight gain and food intake
of both the wild-type and the Gck
+/2 mice fed either the
SO or the SL diet were similar to those of animals fed a
standard chow diet. Adipocyte hypertrophy and increased
inﬂammatory cytokines were not observed in this model,
and insulin sensitivity was essentially unaffected. The blood
glucose levels after insulin injection were found to be
lower in mice fed the SO or the SL diet than in mice fed
the standard chow diet (data not shown). This ﬁnding is
consistent with that of a previous report indicating that the
blood glucose levels after insulin injection in the high-
sucrose diet–fed mice were lower than those in mice fed the
standard diet (36). However, the existence of hepatic in-
sulin resistance was suggested by the increased expression
of PEPCK and G6Pase in the liver. Similar to human type 2
diabetes, the pathogenic mechanisms underlying this model
have a genetic basis (Gck
+/2), yet they also depend more on
environmental factors (diet).
FIG. 4. DFS improved glucose tolerance and insulin secretion in SL diet–fed Gck
+/2 mice. A: Experimental protocol. Both the wild-type and Gck
+/2
mice were fed standard chow until 8 weeks of age and then given free access to the experimental diets. Experiments were performed on wild-type
(WT)a n dGck
+/2 mice after 20 weeks on the SL or the SL-plus-DFS diet. B: Insulin tolerance (n =9 –10). C and D: Glucose tolerance (n =9 –10).
C: Plasma glucose levels. ●, wild-type SL mice; □, wild-type SL-plus-DFS mice; ▲,G c k
+/2 SL mice; ■,G c k
+/2 SL-plus-DFS mice. AUC, area under
the curve. D: Serum insulin levels. *P < 0.05. **P < 0.01. †P < 0.05 vs. Gck
+/2 SL.
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lesterol, and triglyceride were observed in the wild-type
and Gck
+/2 mice fed the SO and SL diets, suggesting that
the adipose tissue inﬂammation induced by SL was not
explained by obesity or dyslipidemia alone. Therefore,
hyperglycemia may be a critical risk factor for fatty acid–
induced adipose tissue inﬂammation. Because palmitic
acid is well known to induce inﬂammation, a diet rich in
palmitic acid may aid the elucidation of the mechanism of
nutrient-induced adipose tissue inﬂammation.
The results regarding the adipocyte size and adiponectin
level suggested that the accumulation of CD8
+ T-cells and
M1 macrophages is an essential prerequisite but is not
sufﬁcient for adipocyte hypertrophy. The increased ex-
pression of E-selectin induced by linoleic acid has been
reported in endothelial cells (37), and this might be a sim-
ilar mechanism of SL-induced E-selectin and P-selectin
expression in adipose tissue. Exposure to dietary FFAs on
adipose tissue macrophages regulates the expression of
PAI-1 (25), but FFA was not increased in this model. The
SL diet–induced upregulation of PAI-1 expression might be
caused by FFA-independent mechanisms. Linoleic acid is
converted to arachidonic acid in vivo, and arachidonic acid
is converted to prostaglandins, leukotrienes, and other lipid
mediators by lipoxygenase or cyclooxygenase (38). Re-
cently, 5-lipoxygenase, which generates leukotrienes from
arachidonic acid, has been reported to induce adipose
tissue inﬂammation (39), and endothelial 15-lipoxygenase
and 12/15-lipoxygenase have been reported to be inducers
of atherosclerosis via a monocyte-endothelial interaction
(40). We noted that the tissue content of arachidonic acid
was signiﬁcantly increased in mice fed an SL diet com-
pared with mice fed an SO diet (E.T. and K.A., unpublished
data). The SL diet–induced adipose tissue inﬂammation
may be partly mediated by the increased expression of
selectins, the production of PAI-1, or the activation of the
arachidonic acid cascade.
Given that a signiﬁcant difference in body weight gain in
the SL-fed Gck
+/2 mice was observed only after week 17,
the protective effects of DFS on adipose tissue and the
liver were not fully explained by the suppressed body
weight gain alone. By contrast, the reduced body weight
gain might at least partly be due to a reduction in visceral
fat accumulation induced by DFS. DFS reportedly exhibited
as i g n i ﬁcantly reduced body weight gain in high-fat diet–fed
mice, but no signiﬁcant differences in food intake, oxygen
consumption, or locomotor activity were observed after
chronic DFS administration (20). DPP4-deﬁcient mice also
demonstrated a resistance to diet-induced obesity (41).
Because clinical data suggest that DPP-4 inhibitors have
a neutral effect on body weight (42), the reduced body
weight gain by DPP-4 inhibition may be associated with
species speciﬁcity. Our results suggest that the increased
expressions of E-selectin and P-selectin on the SL diet
were not required for the DFS-mediated suppression of
adipose tissue inﬂammation, and neither DFS nor GLP-1
directly affected the phase of cytokine production from
CD8
+ T-cells that mediated macrophage recruitment to the
fat tissue. Therefore, DFS might modify the migration of
T-cells or the interactions of intercellular adhesion mole-
cules among T-cells, endothelial cells, and stromal cells.
The GIP receptor, but not the GLP-1 receptor, is expressed
in adipose tissue. Thus, the increase in active GLP-1 arising
from DPP-4 inhibition may not stimulate adipocytes di-
rectly. Because GIP receptor-deﬁcient mice had a lower
weight and a lower adiposity (43), it seems unlikely that
the increase in active GIP arising from the inhibition of
DPP-4 caused a reduction in visceral fat. Nevertheless,
the effects of GIP or other peptides on adipose tissue in-
ﬂammation remain unclear. DFS may affect certain che-
mokines whose activities are regulated by DPP-4. The
interaction and recruitment of adipose tissue T-cells and
macrophages remain controversial. Further study is needed
to elucidate the molecular mechanisms of the DFS-mediated
prevention of CD8
+ T-cells and the M1 macrophage
inﬁltration of adipose tissues, enabling the therapeutic
potential of DPP-4 inhibition in adipose tissue to be de-
termined.
The consumption of sucrose or fructose, but not glu-
cose, reportedly induced hepatic de novo lipogenesis,
postprandial dyslipidemia, and obesity in both animal
models and humans (44–46). In this study, sucrose, rather
than fatty acids, played a dominant role in the induction of
steatosis because an isocaloric palatinose-rich diet did not
induce steatosis. In human hepatocytes, the expressions
of GLP-1 receptor and GLP-1 receptor internalization by
GLP-1 or exendin-4 have been reported (15); however,
GLP-1 receptor expression in the liver has been a contro-
versial issue. A recent study showed that the dephos-
phorylation of eukaryotic initiation factor 2a by GADD34
in the liver resulted in attenuation of hepatic steatosis (47),
raising the possibility that the prevention of liver steatosis
by DFS was due to a reduction in endoplasmic reticulum
stress in the liver by GLP-1R signaling, similar to the sit-
uation in pancreatic b-cells. The effects of sitagliptin on
postprandial lipoprotein metabolism may be involved in the
TABLE 2
Effects of DFS at week 20 on body weight, liver weight, epididymal fat weight, blood glucose level, and serum insulin concentration
after a 16-h fast in wild-type and Gck
+/2 mice
Wild-type Gck
+/2
SL SL + DFS SL SL + DFS
Body weight (g) 37.26 6 2.63 35.36 6 2.49 38.73 6 1.79* 34.61 6 0.85
Liver weight (g) 1.75 6 0.14 1.64 6 0.09 1.81 6 0.20 1.46 6 0.22
Epididymal fat weight (g) 0.98 6 0.25 0.81 6 0.12 1.54 6 0.23* 0.93 6 0.19
Liver weight/body weight (%) 4.79 6 0.53 4.75 6 0.52 4.65 6 0.40 4.17 6 0.55
Epididymal fat weight/body weight (%) 2.57 6 0.58 2.58 6 0.39 4.17 6 0.54 2.65 6 0.51
Glucose (mg/dL) 114 6 8† 99 6 5† 162 6 9 142 6 6
Insulin (ng/mL) 0.52 6 0.057 0.57 6 0.028 0.57 6 0.055 0.61 6 0.047
Data are means 6 SE. n =6 –10. DFS reduced body weight by 5.1% in wild-type mice and by 10.6% in Gck
+/2 mice, although the reduction was
not statistically signiﬁcant in wild-type mice. *P , 0.05 relative to wild-type SL, wild-type SL + DFS, and Gck
+/2 SL + DFS. †P , 0.05 relative to
Gck
+/2 SL and Gck
+/2 SL + DFS.
J. SHIRAKAWA AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, APRIL 2011 1253prevention of fatty liver and the reduction of liver triglyc-
erides (48). The high chronic exposure to insulin can cause
peripheral insulin resistance due to the insulin-induced
adipogenesis and obesity, whereas insulin resistance also
induces steatosis by increased hepatic lipogenesis. In the
current study, despite the insulin resistance in liver the mice
were insulin sensitive at the whole-body level, and DFS in-
creased hepatic insulin sensitivity by preventing hepatic
steatosis and decreasing the expression of PEPCK and
G6Pase. Therefore, our results imply the possible involve-
ment of DPP-4 in the complex interplay between adipose
tissue and liver in the development of insulin resistance.
In summary, we created a model of nutrient-induced
visceral fat inﬂammation in a diabetic state and showed
that DPP-4 inhibition with DFS ameliorated adipose tissue
inﬁltration and NAFLD. Because the biological activities
of the large number of chemokines, adipokines, neuro-
peptides, and incretins are modiﬁed by DPP-4–mediated
FIG. 5. DFS prevented SL-induced adipose tissue inﬁltration by M1 macrophages and expression of PAI-1. A: Histogram of adipocyte size of the
epididymal fat (n =5 ) .B and C: Serum leptin and adiponectin levels (n =6 –8). D and E: Epididymal fat tissue was stained with anti-F4/80 antibody.
The number of CLSs was counted as described in RESEARCH DESIGN AND METHODS (n =5 ) .F: Epididymal fat tissue was stained with anti-CD11c antibody
and DAPI. G: Epididymal fat tissue was stained with anti–PAI-1 antibody and anti-CD11c antibody. Experiments were performed on wild-type (WT)
and Gck
+/2 mice after 25 weeks on the SO or SL diet. H: Assessment of the level of expression of the mRNAs indicated in epididymal fat as determined by
real-time quantitative RT-PCR and normalization to the b-actin mRNA level (n = 5). Experiments were performed on wild-type and Gck
+/2 mice
after 20 weeks on the SL or the SL-plus-DFS diet. *P < 0.05. **P < 0.01. (A high-quality digital representation of this ﬁgure is available in the
online issue.)
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pleiotrophic effects. The results of the current study
demonstrate a novel therapeutic potential of DPP-4 in-
hibitor for extrapancreatic effects in diabetic patients, but
further research is needed to clarify the mechanisms.
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